Greenfire Resources cut to market perform from outperform by BMO; target price lowered to C$11 from C$11.5
GFR•BMO cut Greenfire Resources to market perform from outperform and lowered its target price to C$11 from C$11.5.
Related News
Ionis Pharmaceuticals participates in fireside chats at four investor conferences
IONS•
Ovid Therapeutics Q3 net loss widens as R&D spending rises
OVID•
Humacyte Q3 net loss narrows 11% year over year to $15.54 million
HUMA•
EU-US deal on pharmaceutical trade must be respected, EU says
XLV•
Sionna Therapeutics posts higher-than-expected Q3 net loss on restructuring costs
SION•